OBI held the 2025 Investors’ Meeting, outlining progress in ADC R&D and clinical development, business strategy, and operating efficiency, while advancing next-generation ADC technologies.
#OBIPharma #ADC #Oncology #PrecisionMedicine #InvestorsMeeting
www.obipharma.com/news/obi-inv...
0
0
0
0